Meghana Keshavan

Meghana Keshavan

Meghana has spent the last year-and-a-half writing about biotech and healthcare for the San Diego Business Journal. Previously, she's worked for Reuters, Crain’s Detroit Business, the Detroit Free Press and WDET, a Detroit-based National Public Radio affiliate. Meghana studied biochemistry and molecular biology at Penn State University and spent five years as a self-described "research peon in a schizophrenia genetics lab."

Follow Meghana Keshavan: Twitter |


Robotic endoscope maker Medrobotics raises $20M

Robotic endoscope maker Medrobotics raises $20M

October 31, 2014 1:24 pm by | 0 Comments

A company that’s created the first robot-assisted flexible endoscopic platform for surgery has raised a nice lump sum – Massachusetts devicemaker Medrobotics has raised $20 million. The dollars will be…


Patrick Soon-Shiong startup gets $25M in personalized medicine space

Patrick Soon-Shiong startup gets $25M in personalized medicine space

October 31, 2014 6:00 am by | 0 Comments

NantBioscience – the personalized medicine subsection of the extraordinarily funded Patrick Soon-Shiong-led startup NantWorks – reported in SEC filings that it’s raised $25 million. This comes soon after the umbrella…



Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

October 31, 2014 6:00 am by | 0 Comments

Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you - based on regulatory filings reported…


Aileron Therapeutics closes $33M to launch clinical trials for solid tumor drug

Aileron Therapeutics closes $33M to launch clinical trials for solid tumor drug

October 30, 2014 12:50 pm by | 0 Comments

A new class of cancer drugs called “stapled peptides” has attracted a nice chunk of venture dollars. Cambridge biotech Aileron Therapeutics – the prime player in this space – just secured $33…


JAMA examines 7 ideas for lowering the risk of medical lawsuits – without tort reform

JAMA examines 7 ideas for lowering the risk of medical lawsuits – without tort reform

October 30, 2014 12:30 pm by | 4 Comments

The threat of being sued for medical malpractice looms over most physicians – but thus far, tort reform’s been failing on the federal level. A new free online JAMA article outlines the…


Stanford spinout developing surgical site wound care snags $6M

Stanford spinout developing surgical site wound care snags $6M

October 30, 2014 6:00 am by | 0 Comments

Prescient Surgical, a Bay Area wound care startup that aims to reduce surgical site infection, has raised about $6 million, according to a regulatory filing. The company’s staying pretty vague…


The game-changers of Cleveland Clinic’s Medical Innovation Summit

The game-changers of Cleveland Clinic’s Medical Innovation Summit

October 29, 2014 4:44 pm by | 0 Comments

Cleveland Clinic released its top 10 medical innovations that it predicts to be gamechangers in 2015. During today’s conference, a group of 10 Cleveland Clinic doctors spoke on each disease,…



Cleveland Clinic working with IBM’s Watson to help docs crunch genetic big data

Cleveland Clinic working with IBM’s Watson to help docs crunch genetic big data

October 29, 2014 4:00 pm by | 0 Comments

The Cleveland Clinic has teamed up with IBM’s cognitive computing system, Watson, to help oncologists sift through the massive amounts of patient genetic data and identify targets for treatment. The…


Cancer and heart disease dominate Cleveland Clinic’s Top 10 Medical Innovations for 2015

Cancer and heart disease dominate Cleveland Clinic’s Top 10 Medical Innovations for 2015

October 29, 2014 11:00 am by | 0 Comments

#MIS2014 Innovation #5 – antibody drug conjugates. Again! Idea around for 30 years, but antibodies better, humanized, understand targets. — Meghana Keshavan (@meghanakeshavan) October 29, 2014 The Cleveland Clinic just…


A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded

A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded

October 29, 2014 6:00 am by | 0 Comments

Seems these days as though breath analysis startups are all the rage – creating diagnostics that provide quick-turnover disease diagnosis. They’re primarily targeted to the public health set – allowing…


Tracking Cleveland Clinic’s Twitterati on Day Two of its Innovation Summit

Tracking Cleveland Clinic’s Twitterati on Day Two of its Innovation Summit

October 29, 2014 5:00 am by | 1 Comments

One of the best ways to track a conference’s tone is to take to the Twitters. At this week’s Cleveland Clinic Medical Innovation Summit, there was much to be said:…


Sleep apnea startup raises $25M, largely from Italian medtech co.

Sleep apnea startup raises $25M, largely from Italian medtech co.

October 28, 2014 2:00 pm by | 0 Comments

Most devices that treat sleep apnea are in the form of high-tech, oxygenated face masks – but a Minnesota startup is taking a different approach, building an implantable device that…


Ha! Why we’ve got to cool it with the unnecessary medical research

Ha! Why we’ve got to cool it with the unnecessary medical research

October 28, 2014 8:23 am by | 0 Comments

Try an experiment with photosynthesis. pic.twitter.com/G4JfhxfKNT — Karen McGrane (@karenmcgrane) October 26, 2014


Venture Capital: Is cancer worth investing in?

Venture Capital: Is cancer worth investing in?

October 28, 2014 6:00 am by | 2 Comments

Cancer’s become a core area of venture capital interest, particularly given the rise of personalized medicine. But in a cluttered marketplace it’s tough to differentiate the worthy from the chaff….


Twitterpated: Cleveland Clinic Medical Innovation Summit, summarized.

Twitterpated: Cleveland Clinic Medical Innovation Summit, summarized.

October 27, 2014 9:00 pm by | 0 Comments

The internets were abuzz with Tweetering day one of the Cleveland Clinic Medical Innovation Summit, tackling the issues of personalized medicine as it relates to cancer therapies. Here are some…